CA2247946A1 - Composition anticachexique - Google Patents
Composition anticachexiqueInfo
- Publication number
- CA2247946A1 CA2247946A1 CA002247946A CA2247946A CA2247946A1 CA 2247946 A1 CA2247946 A1 CA 2247946A1 CA 002247946 A CA002247946 A CA 002247946A CA 2247946 A CA2247946 A CA 2247946A CA 2247946 A1 CA2247946 A1 CA 2247946A1
- Authority
- CA
- Canada
- Prior art keywords
- bond
- substituted
- ring
- group
- formula
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 230000003269 anti-cachectic effect Effects 0.000 title 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 3
- 239000001257 hydrogen Substances 0.000 abstract 3
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical group [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 abstract 2
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- 125000001424 substituent group Chemical group 0.000 abstract 2
- 206010006895 Cachexia Diseases 0.000 abstract 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 239000005864 Sulphur Chemical group 0.000 abstract 1
- 125000001931 aliphatic group Chemical group 0.000 abstract 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical group [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 125000004586 dihydrobenzopyranyl group Chemical group O1C(CCC2=C1C=CC=C2)* 0.000 abstract 1
- 125000000623 heterocyclic group Chemical group 0.000 abstract 1
- 125000001183 hydrocarbyl group Chemical group 0.000 abstract 1
- 150000002431 hydrogen Chemical class 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 229910052760 oxygen Inorganic materials 0.000 abstract 1
- 239000001301 oxygen Substances 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 229910052717 sulfur Inorganic materials 0.000 abstract 1
- 239000011593 sulfur Substances 0.000 abstract 1
- 238000011282 treatment Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/422—Oxazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP8/82845 | 1996-04-04 | ||
| JP8284596 | 1996-04-04 | ||
| JP9/27957 | 1997-02-12 | ||
| JP9027957A JPH09323930A (ja) | 1996-04-04 | 1997-02-12 | 悪液質の予防・治療剤 |
| PCT/JP1997/001148 WO1997037656A1 (fr) | 1996-04-04 | 1997-04-03 | Composition anticachexique |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2247946A1 true CA2247946A1 (fr) | 1997-10-16 |
| CA2247946C CA2247946C (fr) | 2006-10-03 |
Family
ID=37101797
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002247946A Expired - Fee Related CA2247946C (fr) | 1996-04-04 | 1997-04-03 | Composition anticachexique |
Country Status (1)
| Country | Link |
|---|---|
| CA (1) | CA2247946C (fr) |
Cited By (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9278914B2 (en) | 2004-06-07 | 2016-03-08 | University Of Tennessee Research Foundation | SARMs and method of use thereof |
| US9622992B2 (en) | 2012-07-13 | 2017-04-18 | Gtx, Inc. | Method of treating androgen receptor (AR)-positive breast cancers with selective androgen receptor modulator (SARMs) |
| US9730908B2 (en) | 2006-08-24 | 2017-08-15 | University Of Tennessee Research Foundation | SARMs and method of use thereof |
| US9744149B2 (en) | 2012-07-13 | 2017-08-29 | Gtx, Inc. | Method of treating androgen receptor (AR)-positive breast cancers with selective androgen receptor modulator (SARMs) |
| US9844528B2 (en) | 2006-08-24 | 2017-12-19 | University Of Tennessee Research Foundation | SARMs and method of use thereof |
| US9884038B2 (en) | 2004-06-07 | 2018-02-06 | University Of Tennessee Research Foundation | Selective androgen receptor modulator and methods of use thereof |
| US9889110B2 (en) | 2004-06-07 | 2018-02-13 | University Of Tennessee Research Foundation | Selective androgen receptor modulator for treating hormone-related conditions |
| US10010521B2 (en) | 2006-08-24 | 2018-07-03 | University Of Tennessee Research Foundation | SARMs and method of use thereof |
| US10258596B2 (en) | 2012-07-13 | 2019-04-16 | Gtx, Inc. | Method of treating HER2-positive breast cancers with selective androgen receptor modulators (SARMS) |
| US11090283B2 (en) | 2007-09-11 | 2021-08-17 | University Of Tennessee Research Foundation | Solid forms of selective androgen receptor modulators |
-
1997
- 1997-04-03 CA CA002247946A patent/CA2247946C/fr not_active Expired - Fee Related
Cited By (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10662148B2 (en) | 2004-06-07 | 2020-05-26 | University Of Tennessee Research Foundation | Selective androgen receptor modulator and methods of use thereof |
| US9278914B2 (en) | 2004-06-07 | 2016-03-08 | University Of Tennessee Research Foundation | SARMs and method of use thereof |
| US9884038B2 (en) | 2004-06-07 | 2018-02-06 | University Of Tennessee Research Foundation | Selective androgen receptor modulator and methods of use thereof |
| US9889110B2 (en) | 2004-06-07 | 2018-02-13 | University Of Tennessee Research Foundation | Selective androgen receptor modulator for treating hormone-related conditions |
| US10053418B2 (en) | 2004-06-07 | 2018-08-21 | University Of Tennessee Research Foundation | Selective androgen receptor modulator and methods of use thereof |
| US9730908B2 (en) | 2006-08-24 | 2017-08-15 | University Of Tennessee Research Foundation | SARMs and method of use thereof |
| US9844528B2 (en) | 2006-08-24 | 2017-12-19 | University Of Tennessee Research Foundation | SARMs and method of use thereof |
| US10010521B2 (en) | 2006-08-24 | 2018-07-03 | University Of Tennessee Research Foundation | SARMs and method of use thereof |
| US10300037B2 (en) | 2006-08-24 | 2019-05-28 | University Of Tennessee Research Foundation | SARMs and method of use thereof |
| US12053448B2 (en) | 2007-09-11 | 2024-08-06 | University Of Tennessee Research Foundation | Solid forms of selective androgen receptor modulators |
| US11090283B2 (en) | 2007-09-11 | 2021-08-17 | University Of Tennessee Research Foundation | Solid forms of selective androgen receptor modulators |
| US9744149B2 (en) | 2012-07-13 | 2017-08-29 | Gtx, Inc. | Method of treating androgen receptor (AR)-positive breast cancers with selective androgen receptor modulator (SARMs) |
| US10258596B2 (en) | 2012-07-13 | 2019-04-16 | Gtx, Inc. | Method of treating HER2-positive breast cancers with selective androgen receptor modulators (SARMS) |
| US9622992B2 (en) | 2012-07-13 | 2017-04-18 | Gtx, Inc. | Method of treating androgen receptor (AR)-positive breast cancers with selective androgen receptor modulator (SARMs) |
Also Published As
| Publication number | Publication date |
|---|---|
| CA2247946C (fr) | 2006-10-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TW268952B (fr) | ||
| AU3461697A (en) | Heterocyclic compounds, their production and use | |
| CA2247443A1 (fr) | Derives d'acide 4-hydroxy-phenylalcanoique substitue possedant une activite agoniste envers ppar-gamma | |
| MY100124A (en) | Dihydropyridazinones. | |
| FR2672598B1 (fr) | ||
| AU1172999A (en) | Novel apoptosis inhibitors | |
| AU528275B2 (en) | Imidazole derivatives | |
| WO1999009965A3 (fr) | Agent antiinflammatoire | |
| AU2177997A (en) | Anticachectic composition | |
| IE841659L (en) | Allopurinol prodrugs | |
| CA2247946A1 (fr) | Composition anticachexique | |
| HK1072770A1 (en) | Bicyclic compound | |
| MY117092A (en) | Chemotherapeutic pyrrolocarbazole derivatives | |
| CA2014490A1 (fr) | Composes de type diaminoethylene | |
| WO2001010834A3 (fr) | Agents antibacteriens | |
| IL112098A (en) | SULFAMIC ACID ESTERS OF PSEUDO-b-FRUCTOPYRANOSE AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | |
| GR3007460T3 (fr) | ||
| ES8605810A1 (es) | Un procedimiento para la preparacion de compuestos de beta-lactama | |
| IE44316L (en) | Indazole derivatives. | |
| TW328957B (en) | Substituted benzothienylpiperazines, their use as medicaments, and processes for their preparation | |
| PL222294A1 (fr) | ||
| WO1999023092A3 (fr) | 3-aminoalkylamino- 2h-1,4-benzoxazines et 3-aminoalkylamino- 2h-1,4-benzothiazines constituant des ligands specifiques d'un sous-type de recepteur de la dopamine | |
| GR3004851T3 (fr) | ||
| IE44180L (en) | Azaprostaglandins. | |
| ES8607963A1 (es) | "un procedimiento para la preparacion de derivados de imi- dazol triciclicos" |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| MKLA | Lapsed |